Australia markets closed
  • ALL ORDS

    7,391.00
    +87.70 (+1.20%)
     
  • ASX 200

    7,145.60
    +81.10 (+1.15%)
     
  • AUD/USD

    0.7037
    -0.0012 (-0.17%)
     
  • OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD

    1,845.10
    +3.90 (+0.21%)
     
  • BTC-AUD

    41,746.79
    -91.20 (-0.22%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • AUD/EUR

    0.6659
    +0.0002 (+0.03%)
     
  • AUD/NZD

    1.0973
    -0.0065 (-0.59%)
     
  • NZX 50

    11,267.39
    +60.46 (+0.54%)
     
  • NASDAQ

    11,835.62
    -40.01 (-0.34%)
     
  • FTSE

    7,389.98
    +87.24 (+1.19%)
     
  • Dow Jones

    31,261.90
    +8.77 (+0.03%)
     
  • DAX

    13,981.91
    +99.61 (+0.72%)
     
  • Hang Seng

    20,717.24
    +596.56 (+2.96%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     

Fiji Kava Limited (FIJ.AX) Raises $745k Through Convertible Notes Issue

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Fiji Kava Limited
Fiji Kava Limited

Fiji Kava Limited (FIJ.AX) Raises $745k Through Convertible Notes Issue

Brisbane, Australia, May 3, 2022 - (ABN Newswire) - Fiji Kava Ltd (ASX:FIJ), is a health and wellness company with operations in Australia, Fiji, and the USA. The company which produces natural products to reduce anxiety, promote relaxation, improve sleep, and support sports recovery has raised $745,000 through the issue of convertible notes securities.

Fiji Kava CEO, Dr Anthony Noble said: "As the company ramps up entry activities for Kava products into the USA Market and expands distribution of beverage formats in Australia, Fiji and the USA, we are preparing for an uptick in demand for our drinking kava and CBD tincture products. New Australia and USA retail channels will require additional inventory and marketing investments to pipeline fill and support trade spend and marketing programs over the coming 5-18 months. The note structure of this capital raise reflects this timeline while providing us with the required funding for these important growth drivers in Australia and the USA."

*To view key terms, please visit:
https://abnnewswire.net/lnk/0653304O


About Fiji Kava Limited:


Fiji Kava Limited (ASX:FIJ) is a health and wellness company with operations in Australia, Fiji and the USA. The company produces a range of natural products to reduce anxiety, promote relaxation, improve sleep and support sports recovery. These include dietary supplements and complementary medicines in solid dose forms, medicinal tinctures and teas, powdered drinks and functional beverages. Their products are marketed though major retail grocery and pharmacy chains, direct to consumers online and as bulk ingredients though B2B channels. Backed by years of independent research, Fiji Kava medical kava products are produced by high quality GMP and HACCP processes which are fully compliant with TGA and FDA requirements.

Contact:

For Investors
Jay Stephenson
investors@fijikava.com

For Media
Anthony Noble
anthony@fijikava.com

Source:
Fiji Kava Limited

Copyright (C) 2022 ABN Newswire. All rights reserved.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting